Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
National Institutes of Health · National Institute of Allergy and Infectious Diseases · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
750
total citations
- FWCI
- 50.15
- Percentile
- 100%
- References
- 86
Citations per year
Authors
46- NANicole A. Doria‐RoseCorresponding
National Institutes of Health, National Institute of Allergy and Infectious Diseases
- CAChaim A. Schramm
Columbia University
- JGJason Gorman
National Institutes of Health, National Institute of Allergy and Infectious Diseases
- PLPenny L. Moore
National Health Laboratory Service, Centre for the AIDS Programme of Research in South Africa
- JNJinal N. Bhiman
National Health Laboratory Service
Topics & keywords
Topics
Keywords
- Antibody
- Somatic hypermutation
- Virology
- Neutralization
- Biology
- Affinity maturation
- Neutralizing antibody
- Complementarity determining region
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- NSNational Science FoundationAward: W-31-109-Eng-38
- UDU.S. Department of Energy
- WTWellcome Trust
- NRNational Research Foundation
- PRPoliomyelitis Research Foundation
- NINational Institutes of Health
- OOOffice of ScienceAward: W-31-109-Eng-38
- NHNational Human Genome Research Institute
- NINational Institute of General Medical Sciences
- NINational Institute of Allergy and Infectious Diseases
- FIFogarty International Center
- BEBasic Energy SciencesAward: W-31-109-Eng-38